|
SECISBP2L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79459780369484E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.07771602542562E-12 |
| Normal-vs-Stage2 |
2.229900E-04 |
| Normal-vs-Stage3 |
1.81959999956405E-07 |
| Normal-vs-Stage4 |
1.94855999999799E-05 |
| Stage1-vs-Stage2 |
4.684400E-01 |
| Stage1-vs-Stage3 |
8.902800E-01 |
| Stage1-vs-Stage4 |
7.799800E-01 |
| Stage2-vs-Stage3 |
4.691200E-01 |
| Stage2-vs-Stage4 |
4.884800E-01 |
| Stage3-vs-Stage4 |
8.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11369802269223E-11 |
| Normal-vs-AfricanAmerican |
3.8481999808937E-09 |
| Normal-vs-Asian |
1.56518999999689E-05 |
| Caucasian-vs-AfricanAmerican |
7.508000E-01 |
| Caucasian-vs-Asian |
4.554600E-01 |
| AfricanAmerican-vs-Asian |
3.533800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1783464748969E-12 |
| Normal-vs-Female |
1.52529999997153E-06 |
| Male-vs-Female |
1.309820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.06889999973836E-08 |
| Normal-vs-Extreme_Weight |
3.22208926206713E-12 |
| Normal-vs-Obese |
7.11909997619387E-09 |
| Normal-vs-Extreme_Obese |
8.17260000000042E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.372800E-01 |
| Normal_Weight-vs-Obese |
4.607400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.132800E-01 |
| Extreme_Weight-vs-Obese |
1.152630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.373600E-01 |
| Obese-vs-Extreme_Obese |
7.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.36949999965886E-07 |
| Normal-vs-Age(41-60Yrs) |
8.92530005458525E-09 |
| Normal-vs-Age(61-80Yrs) |
2.70627964482628E-12 |
| Normal-vs-Age(81-100Yrs) |
1.8292000025788E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.891000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.154800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.985160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.914500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.512300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.835800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.97489818837471E-11 |
| Normal-VS-Type2 PRCC |
8.17923506701845E-12 |
| Normal-VS-KIRP CIMP |
6.10559999999483E-05 |
| Normal-VS-Unclassified PRCC |
4.570400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.605580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.737000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.967200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.497000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.575900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.098200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48214773787458E-12 |
| Normal-vs-N1 |
1.80660000292931E-08 |
| Normal-vs-N2 |
4.260000E-03 |
| N0-vs-N1 |
6.747200E-01 |
| N0-vs-N2 |
6.514400E-01 |
| N1-vs-N2 |
8.240400E-01 |
|
|
